First Bight Ventures

First Bight Ventures is an early-stage venture capital firm based in Houston, Texas, focused on advancing and accelerating synthetic biology companies. The firm invests in nature's chemistry to disrupt how people and companies consume products, aiming to transition industries from extraction-based models to regenerative ones. Their portfolio includes companies like Algenesis Corporation, which develops sustainable materials, and Visolis, which utilizes synthetic biology to produce bio-based chemicals. First Bight Ventures partners with startups to scale impact by leading funding rounds, taking board seats, making strategic introductions, driving operational efficiencies, and mitigating risks. They emphasize a hands-on approach to support the growth and success of their portfolio companies.

The firm's investment strategy targets sectors such as chemicals, agriculture, energy, consumer goods, pharmaceuticals, and heavy industries. They seek companies with proven science, early commercial momentum, large market potential, exceptional founders, and capital advantages. First Bight Ventures aims to deliver a more sustainable future by scaling the use of biology throughout manufacturing processes. Their approach includes actively engaging with industry stakeholders to drive meaningful partnerships and leveraging their relationships to support portfolio companies.

First Bight Ventures was founded by Veronica Breckenridge, who has over 20 years of experience in scaling innovative industrial processes. The firm's team includes professionals with backgrounds in various industries, including biotechnology, business development, and commercialization. They are committed to building a biomanufacturing ecosystem that makes scientific breakthroughs profitable and works with global stakeholders to scale biomanufacturing in local communities. Their mission is to help society transition from a model of extraction to a model of regeneration, contributing to the advancement of the bioeconomy and sustainable innovation.